Cf 301-105 is a clinical research site located in Omaha, Nebraska, United States 68124.
Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.
Cf 301-105 has participated in 3 clinical trials.
Therapeutic areas: Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Endocarditis, Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia).
Sponsors: ContraFect.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Nebraska · View every site in Omaha
Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Cf 301-105 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Cf 301-105 has 3 clinical trials on record. Their work covers Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Endocarditis, Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia).
Cf 301-105 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.